iShares Core S&P Mid-Cap ETF (IJH)
276.38
+2.94 (+1.08%)
USD |
May 07, 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.05% | -0.02% | 65.15B | 1.245M |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.02% | 15.00% | -668.95M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results of the S&P MidCap 400 (the "underlying index"), which measures the performance of the mid-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Blend |
| Category Index | Russell Mid Cap TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| S&P MidCap 400 TR | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 13.34 yrs |
| Jennifer Hsui | 8.75 yrs |
| Alan Mason | 5.05 yrs |
| Amy Whitelaw | 2.75 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
97
-668.95M
-2.022B
Category Low
3.146B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2021
Performance Versus Category
As of May 07, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of May 07, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Charles River Laboratories International Inc | 0.73% | 342.55 | 1.70% |
| Bio-Techne Corp | 0.68% | 423.05 | 2.94% |
| Molina Healthcare Inc | 0.64% | 267.84 | 1.60% |
| XPO Logistics Inc | 0.62% | 147.00 | 1.84% |
| Signature Bank | 0.62% | 255.06 | 0.60% |
| Fair Isaac Corp | 0.61% | 496.17 | 0.40% |
| Cognex Corp | 0.59% | 77.58 | -1.66% |
| Williams-Sonoma Inc | 0.57% | 186.70 | 1.94% |
| Graco Inc | 0.55% | 78.54 | -0.08% |
| FactSet Research Systems Inc | 0.54% | 337.05 | -0.30% |
News
Headline
Wire
Time (ET)
Business Wire
06/25 17:33
Business Wire
10/05 00:00
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results of the S&P MidCap 400 (the "underlying index"), which measures the performance of the mid-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Blend |
| Category Index | Russell Mid Cap TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| S&P MidCap 400 TR | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 13.34 yrs |
| Jennifer Hsui | 8.75 yrs |
| Alan Mason | 5.05 yrs |
| Amy Whitelaw | 2.75 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-7-21) | 1.02% |
| 30-Day SEC Yield (3-31-20) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 24.14 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 05, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 5/22/2000 |
| Last Annual Report Date | 3/31/2020 |
| Last Prospectus Date | 8/17/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
Business Wire
06/25 17:33
Business Wire
10/05 00:00